Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-07-10 | 2021-01-14 | 119956 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195870 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-07-04 | 2023-10-04 | 197172 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-10-19 | 2024-02-22 | 207536 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-10-19 | 2023-12-07 | 207539 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2022-12-22 | 2023-01-26 | 179309 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2019-10-17 | 2020-06-26 | 96727 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2019-11-28 | 2019-12-06 | 99947 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2022-01-20 | 2023-10-06 | 153171 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2022-01-20 | 2022-12-02 | 153174 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2024-11-08 | 2025-01-09 | 242370 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-03 | 107949 |
TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2020-03-26 | 2020-09-10 | 109607 |
TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2020-05-21 | 2020-08-13 | 115547 |
TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2019-08-29 | 2019-11-21 | 92675 |
TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2022-09-22 | 2023-04-28 | 169973 |
TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176836 |
TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176839 |
TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2019-08-15 | 2019-10-04 | 91645 |
TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2024-12-13 | 2025-01-23 | 245609 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |